Title |
High frequency oscillations in the intra-operative ECoG to guide epilepsy surgery (“The HFO Trial”): study protocol for a randomized controlled trial
|
---|---|
Published in |
Trials, September 2015
|
DOI | 10.1186/s13063-015-0932-6 |
Pubmed ID | |
Authors |
Maryse A. van ’t Klooster, Frans S. S. Leijten, Geertjan Huiskamp, Hanneke E. Ronner, Johannes C. Baayen, Peter C. van Rijen, Martinus J. C. Eijkemans, Kees P. J. Braun, Maeike Zijlmans, on behalf of the HFO study group |
Abstract |
Intra-operative electrocorticography, based on interictal spikes and spike patterns, is performed to optimize delineation of the epileptogenic tissue during epilepsy surgery. High frequency oscillations (HFOs, 80-500 Hz) have been identified as more precise biomarkers for epileptogenic tissue. The aim of the trial is to determine prospectively if ioECoG-tailored surgery using HFOs, instead of interictal spikes, is feasible and will lead to an equal or better seizure outcome. METHODS\DESIGN: We present a single-blinded multi-center randomized controlled trial "The HFO Trial" including patients with refractory focal epilepsy of all ages who undergo surgery with intra-operative electrocorticography. Surgery is tailored by HFOs (arm 1) or interictal spikes (arm 2) in the intra-operative electrocorticography. Primary outcome is post-operative outcome after 1 year, dichotomized in seizure freedom (Engel 1A and 1B) versus seizure recurrence (Engel 1C-4). Secondary outcome measures are the volume of resected tissue, neurologic deficits, surgical duration and complications, cognition and quality of life. The trial has a non-inferiority design to test feasibility and at least equal performance in terms of surgical outcome. We aim to include 78 patients within 3 years including 1 year follow-up. Results are expected in 2018. This trial provides a transition from observational research towards clinical interventions using HFOs. We address methodological difficulties in designing this trial. We expect that the use of HFOs as a biomarker for tailoring will increase the success rate of epilepsy surgery while reducing resection volume. This may reduce neurological deficits and yield a better quality of life. Future technical developments, such as validated automatic online HFO identification, could, together with the attained clinical knowledge, lead to a new objective tailoring approach in epilepsy surgery. This trial is registered at the US National Institutes of Health (ClinicalTrials.gov) #NCT02207673 (31 July 2014) and the Central Committee on Research Involving Human Subjects, The Netherlands #NL44257.041.13 (18 March 2014). |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 2 | 1% |
Brazil | 1 | <1% |
Unknown | 152 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 23 | 15% |
Student > Ph. D. Student | 22 | 14% |
Researcher | 17 | 11% |
Student > Bachelor | 12 | 8% |
Student > Doctoral Student | 11 | 7% |
Other | 24 | 15% |
Unknown | 46 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 41 | 26% |
Neuroscience | 20 | 13% |
Engineering | 15 | 10% |
Agricultural and Biological Sciences | 5 | 3% |
Psychology | 5 | 3% |
Other | 18 | 12% |
Unknown | 51 | 33% |